We found that pathogenic germline variants in MMR genes were rare in consecutive breast cancers (15/8085, 0.19%), and germline variants were more common in PMS2/MSH6 genes than in MLH1/MSH2 genes in breast cancers. This evidence concerns the gene MSH2 and breast cancer.